Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any
discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Summary of Non-Consolidated Financial Results
for the Three Months Ended June 30, 2021
(Based on Japanese GAAP)
July 30, 2021
Company name:
DAIKEN MEDICAL CO., LTD.
Stock exchange listing: Tokyo
Stock code:
Representative:

7775
President

URL

http://www.daiken-iki.co.jp
Keiichi Yamada

Inquiries:

General Manager Finance and Accounting
DivisionToshikazu Itami

Scheduled date to file Quarterly Securities Report:
Scheduled date to commence dividend payments:

August 2, 2021–

Preparation of supplementary material on quarterly financial results:
Holding of quarterly financial results meeting:

NoNo

TEL

06-6231-9917(Amounts less than one million yen are rounded down)
1. Non-consolidated financial results for the three months ended June 30, 2021 (from April 1, 2021 to June 30, 2021)(1) Non-consolidated operating results (cumulative)
Percentages indicate year-on-year changes
Net sales
Three months ended June 30, 2021
Three months ended June 30, 2020

Operating profit

Millions of yen
1,977
1,790

% Millions of yen
10.4
249(13.0)
191

Earnings per share

Ordinary profit% Millions of yen
30.3
249(38.4)
191%
29.1(41.4)

Diluted earnings per share
Yen
6.14
4.75

Three months ended June 30, 2021
Three months ended June 30, 2020

Profit% Millions of yen
30.4
176(41.2)
136

Yen––(2) Non-consolidated financial position
Total assets

Net assets

Millions of yen
10,724
10,752As of June 30, 2021
As of March 31, 2021

Equity ratio

Millions of yen
6,042
6,182%
56.3
57.5

2. Cash dividends
Annual dividends per share
1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Yen––

Yen
9.00

Yen–

Yen
11.00

Yen
20.00

9.00

–

11.00

20.00

Year ended March 31, 2021
Year ending March 31, 2022
Year ending March 31, 2022 (Forecast)Total

3. Forecast of non-consolidated financial results for the year ending March 31, 2022 (from April 1, 2021 to March 31, 2022)
Percentages indicate year-on-year changes
Net sales
Millions of yenSix months ending
September 30, 2021
Full year

Operating profit% Millions of yen

Ordinary profit% Millions of yen

ProfitEarnings per share% Millions of yen%

Yen

4,350

15.3

510

12.7

510

4.3

360

2.7

12.53

9,000

14.5

1,200

30.3

1,200

25.4

840

24.4

29.24

1

4. Notes(1) Application of special accounting methods for preparing quarterly non-consolidated financial statements: Yes(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
Changes in accounting policies due to revisions to accounting standards and other regulations:
Yes
Changes in accounting policies due to other reasons:
Changes in accounting estimates:

NoNo

Restatement of prior period financial statements:

No(3) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of June 30, 2021

31,840,000 shares As of March 31, 2021

31,840,000 shares

Number of treasury shares at the end of the period
As of June 30, 2021

3,111,559 shares As of March 31, 2021

3,111,559 shares

Average number of shares during the period (cumulative from the beginning of the fiscal year)
Three months ended June 30, 2021

28,728,441 shares Three months ended June 30, 2020

228,728,441 shares

Quarterly non-consolidated financial statements
Non-consolidated balance sheets(Thousands of yen)
As of March 31, 2021

As of June 30, 2021

AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade2,170,643
1,597,757

2,418,145
1,286,824

Electronically recorded monetary claims - operating
Finished goods

989,922
891,412

963,964
946,036

Work in processRaw materials

86,665443,833

64,032
479,023

Other
Allowance for doubtful accounts

92,402(87)

117,988(87)

6,272,550

6,275,928

2,019,367
1,703,670

1,996,846
1,703,670

Total current assets
Non-current assets
Property, plant and equipment
Buildings, net
Land
Other, net

502,053495,049

4,225,091

4,195,567

Intangible assets

21,723

19,655Investments and other assets
Deferred tax assets

166,802

166,80291,404(24,650)

90,994(24,650)

Total property, plant and equipment

Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets

3

233,555

233,145

4,480,370

4,448,368

10,752,921

10,724,296

(Thousands of yen)
As of March 31, 2021

As of June 30, 2021

Liabilities
Current liabilities
Notes and accounts payable - trade
Electronically recorded obligations - operating

849,189
141,925

512,815452,059

1,000,000
704,034

1,500,000
666,534

Income taxes payable
Accrued expenses

111,074
179,500

84,430158,398

Provision for Sales allowance
Asset retirement obligations

179,346
6,738–6,720

Short-term borrowings
Current portion of long-term borrowings

Other

175,208

241,564

3,347,018

3,622,523

Long-term borrowings
Other

1,177,859
45,7681,015,913
43,291

Total non-current liabilities

1,223,627

1,059,204

4,570,645

4,681,728

Shareholders' equity
Share capital

495,875

495,875

Capital surplus
Retained earnings

400,875
7,112,107

400,875
6,972,400

Treasury shares(1,826,582)(1,826,582)

Total shareholders' equity

6,182,275

6,042,567

6,182,275

6,042,567

10,752,921

10,724,296

Total current liabilities
Non-current liabilities

Total liabilities
Net assets

Total net assets
Total liabilities and net assets

4Non-consolidated statements of income (cumulative)(Thousands of yen)Three months ended

Three months ended

June 30, 2020

June 30, 2021

Net sales
Cost of sales

1,790,803
981,733

1,977,150
1,109,054

Gross profit

809,070868,095

Selling, general and administrative expenses

617,979

619,071

Operating profit

191,090

249,024

Foreign exchange gains
Gain on forfeiture of unclaimed dividends

202814311
544

Compensation income
Other–330

381
2391,347

1,477

955

960

Non-operating income

Total non-operating income
Non-operating expenses
Interest expenses
Other106–

1,061

960

191,376

249,541

145

298

145

298

Profit before income taxes

191,230

249,243

Income taxes

54,67072,938

Profit136,560

176,305

Total non-operating expenses
Ordinary profit
Extraordinary losses
Loss on retirement of non-current assets
Total extraordinary losses

5